Search Details

Word: rosing (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

Healthcare spending in 2009 rose to $2.5 trillion, a global summit on climate change came and went, and, a year out of the greatest financial crisis since the Great Depression, we still aren’t regulating derivatives. Nothing got done...

Author: By Clay A. Dumas | Title: Tyranny of the Minority | 2/17/2010 | See Source »

...seeing their business pick up. "There has definitely been a surge in the past 12 to 18 months," says Fred Tomczyk, chief executive of TD Ameritrade. "We've had very good growth trends." In TD Ameritrade's fiscal first quarter that ended on Dec. 31, 2009, net new assets rose to $8.7 billion from $7.8 billion a year earlier, according to Kim Hillyer, the company's senior manager of communications...

Author: /time Magazine | Title: Brokers Wage a Price War on Commissions | 2/16/2010 | See Source »

...ball is now in TD Ameritrade's court, a firm that has been gaining market share in recent years, with its flat $9.99 fee. In 2009, TD Ameritrade's daily average revenue [producing] trades rose 17% while Schwab's fell 2%, said Michael Hecht, an analyst at JMP Securities, in a recent note. "We were the one shop that had simple, straightforward, transparent pricing - one price point for all clients and there's no gimmick to it," says Tomczyk. "Clients don't like it when think they have one price and wind up getting nickeled and dimed to death...

Author: /time Magazine | Title: Brokers Wage a Price War on Commissions | 2/16/2010 | See Source »

Simon—who graduated from Harvard Kennedy School in 1997—took a job as Harvard Hillel Programming Director in 2003 after he contacted Harvard Hillel Director Bernard Steinberg. Simon later rose to the position of Associate Director...

Author: By Julia R Jeffries, CONTRIBUTING WRITER | Title: Hillel Associate Director To Leave for Northwestern | 2/16/2010 | See Source »

Like much of the rest of the health care sector, the drug-wholesaling industry has proved mostly recession-proof. Revenue rose 8% in 2008, to $386 billion, and an additional 6% bump is expected for last year, according to Pembroke Consulting, a Philadelphia distribution and manufacturing consultancy. Plus, an aging population and reform will be extra boons. "In theory, more insured people should mean more drug utilization," says Adam J. Fein, an economist and the founder of Pembroke. "That means more money in the pockets of wholesalers...

Author: /time Magazine | Title: Prescription for a Turnaround | 2/15/2010 | See Source »

Previous | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | Next